Status
Conditions
Treatments
About
Observational study. Participants of the FRASNET study (9th March 2017, Protocol No. 24/INT/2017) who were evaluated in 2016 and 2017 will be contacted to be re-evaluated with multidimensional visits as part of the present study in order to assess trajectories and biomarkers of frailty and sarcopenia. Moreover, are going to evaluate with the same multidimensional visits patients with mild cognitive impairment and dementia followed up at the Neurologic Unit of the San Raffaele Hospital.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
500 participants in 2 patient groups
Loading...
Central trial contact
Sarah Damanti, PhD, MD; Patrizia Rovere Querini, PhD, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal